Abstract
Background
The objective of the present study was twofold: to demonstrate our experience with unilateral adrenalectomy in the treatment of adrenocorticotropic hormone (ACTH)-independent Cushing syndrome (CS) caused by bilateral adrenocortical hyperplasias, and to evaluate the long-term results as evidenced by the main laboratory and clinical findings.
Methods
From February 2000 to August 2009, unilateral adrenalectomy was performed on 27 patients with ACTH-independent CS and bilateral adrenocortical hyperplasias, including 14 patients with ACTH-independent macronodular adrenal hyperplasia (AIMAH) and 13 patients with primary pigmented nodular adrenocortical disease (PPNAD). Signs and symptoms of CS, endocrine examinations, and radiographic imaging were evaluated preoperatively and postoperatively.
Results
At a median follow-up of 69 months (range: 23–120 months) for AIMAH and 47 months (range: 16–113 months) for PPNAD, 25 patients were cured by unilateral adrenalectomy. Serum cortisol level, daily urinary free cortisol (UFC), and plasma ACTH regained the normal range in both AIMAH and PPNAD patients at monthly follow-up visits; the circadian serum cortisol rhythm returned to normal, and a normal responsiveness to overnight low-dose dexamethasone administration (LDDST) became obvious. Both systolic and diastolic blood pressure (BP) levels were significantly reduced: 85 % of patients recovered normal BP levels, and the remaining patients need antihypertensive drugs, but at a reduced dose. No surgery-related morbidity occurred, and there was no sign of further enlargement of the residual adrenal gland after successful unilateral adrenalectomy. One patient with PPNAD and another patient with AIMAH with similar weights and sizes of the bilateral adrenals needed contralateral adrenalectomy.
Conclusions
Unilateral adrenalectomy may be the suitable treatment for selected patients with AIMAH and PPNAD. It can achieve long-term remission of CS and improve glycemic control and BP values.
Similar content being viewed by others
References
Lacroix A, Bourdeau I (2005) Bilateral adrenal Cushing’s syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinol Metab Clin North Am 34:441–458 x
Iacobone M, Albiger N, Scaroni C et al (2008) The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J Surg 32:882–889. doi:10.1007/s00268-007-9408-5
Stratakis CA, Kirschner LS (1998) Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30:456–463
Lamas C, Alfaro JJ, Lucas T et al (2002) Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia?: long-term follow-up of four cases. Eur J Endocrinol 146:237–240
Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602
Bertagna X, Guignat L, Groussin L et al (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623
Ilias I, Torpy DJ, Pacak K et al (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955–4962
Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526–1540
Gunther DF, Bourdeau I, Matyakhina L et al (2004) Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89:3173–3182
Kirschner MA, Powell RD Jr, Lipsett MB (1964) Cushing’s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 24:947–955
Aiba M, Hirayama A, Iri H et al (1991) Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing’s syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol 96:334–340
Lacroix A, Ndiaye N, Tremblay J et al (2001) Ectopic and abnormal hormone receptors in adrenal Cushing’s syndrome. Endocr Rev 22:75–110
Zeiger MA, Nieman LK, Cutler GB et al (1991) Primary bilateral adrenocortical causes of Cushing’s syndrome. Surgery 110:1106–1115
Stratakis CA, Kirschner LS, Carney JA (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041–4046
Goodarzi MO, Dawson DW, Li X et al (2003) Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. J Clin Endocrinol Metab 88:73–77
Lacroix A (2009) ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:245–259
Doppman JL, Nieman LK, Travis WD et al (1991) CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. J Comput Assist Tomogr 15:773–779
Doppman JL, Chrousos GP, Papanicolaou DA et al (2000) Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 216:797–802
Newell-Price J, Bertagna X, Grossman AB et al (2006) Cushing’s syndrome. Lancet 367:1605–1617
Doppman JL, Travis WD, Nieman L et al (1989) Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 172:415–420
Sahdev A, Reznek RH, Evanson J et al (2007) Imaging in Cushing’s syndrome. Arq Bras Endocrinol Metab 51:1319–1328
Shen WT, Lee J, Kebebew E et al (2006) Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg 141:771–774 discussion 774–776
Storr HL, Mitchell H, Swords FM et al (2004) Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing’s syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 61:553–559
Sato M, Soma M, Nakayama T et al (2006) A case of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) with primary hyperparathyroidism (PHPT). Endocr J 53:111–117
Vezzosi D, Cartier D, Regnier C et al (2007) Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol 156:21–31
Acknowledgments
This study was supported by a grant from the National Natural Science Foundation of China (No. 81272936).
Author information
Authors and Affiliations
Corresponding author
Additional information
Wenbin Rui is listed as co-first author.
Rights and permissions
About this article
Cite this article
Xu, Y., Rui, W., Qi, Y. et al. The Role of Unilateral Adrenalectomy in Corticotropin-Independent Bilateral Adrenocortical Hyperplasias. World J Surg 37, 1626–1632 (2013). https://doi.org/10.1007/s00268-013-2059-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-013-2059-9